Literature DB >> 13248870

The pathogenesis of anemia in patients with carcinoma.

G A HYMAN, J E HARVEY.   

Abstract

Entities:  

Keywords:  ANEMIA; HEMOLYSIS; NEOPLASMS/complications

Mesh：

Year:  1955        PMID： 13248870     DOI： 10.1016/0002-9343(55)90123-6

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  9 in total

1.  The extrarenal manifestations of hypernephroma.

Authors:  D A GORDON
Journal:  Can Med Assoc J       Date:  1963-01-12       Impact factor: 8.262

2.  Management of disseminated neoplastic disease: hematological problems.

Authors:  A B LEY; R R ELLISON
Journal:  Bull N Y Acad Med       Date:  1957-10

3.  ANAEMIA in malignant disease.

Authors: 
Journal:  Br Med J       Date:  1956-03-03

4.  Sideropenic anaemia with reticulo-endothelial siderosis in a case of hypernephroma.

Authors:  K Chatterjee; G E MacLellan
Journal:  Postgrad Med J       Date:  1968-03       Impact factor: 2.401

5.  [Plasma iron turnover before and following cytostatic therapy and its signifiance as indicator of tumor activity].

Authors:  B Messmer
Journal:  Klin Wochenschr       Date:  1968-12-01

6.  Transferrin receptors in human tissues: their distribution and possible clinical relevance.

Authors:  K C Gatter; G Brown; I S Trowbridge; R E Woolston; D Y Mason
Journal:  J Clin Pathol       Date:  1983-05       Impact factor: 3.411

7.  Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer.

Authors:  Suzana Kukulj; Morana Jaganjac; Milivoj Boranic; Simun Krizanac; Zarko Santic; Marija Poljak-Blazi
Journal:  Med Oncol       Date:  2009-03-24       Impact factor: 3.064

8.  Transient warm autoimmune hemolytic anemia and cryoglobulinemia associated with seminoma.

Authors:  W B Lundberg; M S Mitchell
Journal:  Yale J Biol Med       Date:  1977 Jul-Aug

9.  Anaemia in patients with solid tumours and the role of erythrocyte deformability.

Authors:  C E Mercke
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.